FTC’s Reporting Rule for Pharmaceutical Patent Transfers Upheld

By | Antitrust Alert | June 4, 2014

On May 30, 2014, the U.S. District Court for the District of Columbia ruled in favor of the Federal Trade Commission (FTC) in a dispute with the Pharmaceutical Research and Manufacturers of America (PhRMA) regarding the Commission’s authority to require the pharmaceutical industry to report certain transfers of exclusive patent rights under the Hart-Scott-Rodino (HSR) Act.

FTC Releases Report On Data Brokers, and Legislative Action May Be Around the Corner

FTC Releases Report On Data Brokers, and Legislative Action May Be Around the Corner

On May 27, 2014, the FTC released its report “Data Brokers: A Call for Transparency and Accountability”. In the report, the FTC advocates for more transparency from data brokers, defined in the report as “companies that collect consumers’ personal information and resell or share that information with others.” 

The Other Ski Boot Drops – You Shouldn’t Collude Over Endorsers Either

The Other Ski Boot Drops – You Shouldn’t Collude Over Endorsers Either

For those that have adjusted to the fact that the FTC and the Antitrust Division of the Department of Justice really do care if you agree with your competitors to not recruit each other’s employees (for which, see this recent reminder from DOJ involving E-Bay’s alleged involvement in the scheme among high-tech companies to avoid “poaching” each other’s employees), the FTC just settled an investigation of two ski manufacturers that allegedly agreed not to solicit each other’s endorsers along with an agreement not to solicit each other’s employees.